Search & Filter

Nearly one-quarter of patients with a mechanical heart valve say it disturbs their sleep, according to research also presented at EuroHeartCare 2017.

Heart failure and stroke has been identified as a lethal combination, with heart failure patients how have had previous strokes having greater risks of depression, hospitalisation and death than those without a history of stroke.

A new study suggests that men and women are affected differently by sleep disorders.

The first European study into the burden of non-tuberculosis mycobacterium pulmonary disease (NTM-PD) has been published in the European Respiratory Journal.

A new study has found that certain factors are linked with a person's decision to leave the hospital against the advice of his or her care provider.

A motor mechanism that has been attributed primarily to early development in babies can also help older adults improve movement accuracy, according to new research.

Results of the DEVOTE trial investigating the cardiovascular (CV) safety profile of long-acting insulin, insulin degludec (Tresiba), in adults with type 2 diabetes were presented at the American Diabetes Association (ADA) congress. 

Analysis of the LEADER cardiovascular (CV) outcomes trial found that treatment with Victoza (liraglutide) 1.8mg once daily resulted in similar reductions in the risk of major CV events in adults with type 2 diabetes (T2D) at high CV risk, regardless of whether or not they experienced an episode of severe hypoglycaemia during the trial.

Novo Nordisk has announced the full results of the DEVOTE trial investigating the cardiovascular (CV) safety profile of long-acting insulin Tresiba (insulin degludec), in adults with type 2 diabetes (T2D).

New findings from a post-hoc analysis of the LEADER cardiovascular (CV) outcomes trial were presented recently at the 77^th annual Scientific Sessions of the American Diabetes Association (ADA).

Taking one or more blood pressure medications at night rather than on waking might help manage hypertension and cardiovascular disease and, in patients with particular problems with blunted nocturnal blood pressure dipping, it may be worth considering.

The use of implantable devices are on the rise and may be used for diagnostic monitoring as well as a treatment option. The requirement for MRI in patients is not an absolute contraindication especially with new devices.

Syncope is a sudden, but brief loss of consciousness caused by inadequate perfusion to the brain. It is typically characterised by a loss of postural tone, and a spontaneous return to baseline neurological function and usually requiring no resuscitative efforts.

Diabetes increases the risk of frailty through inducing sarcopenia or muscle mass loss. Prevention programmes in the pre-frail state through exercise training, nutrition and glycaemic control may delay or prevent the development of frailty.

Sodium-glucose transporter-2 (SGLT2) inhibitors are associated with lower rates of death and hospitalisation for heart failure when used to treat patients with type 2 diabetes